AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


American Journal of Public Health, Vol. 83, Issue 4 498-500, Copyright © 1993 by American Public Health Association

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gollub, E L
Right arrow Articles by Stein, Z A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gollub, E L
Right arrow Articles by Stein, Z A
Commentary: the new female condom--item 1 on a women's AIDS prevention agenda.

E L Gollub and Z A Stein

HIV Center for Clinical and Behavioral Studies, New York State Psychiatric Institute, Columbia University, NY 10032.

A US Food and Drug Administration (FDA) advisory panel has recommended that the female condom Reality be approved for contraception and acquired immunodeficiency syndrome (AIDS) prevention. Final FDA approval will mark the first official recognition of a woman-controlled method for protection against sexually transmitted disease. A female condom allows women to use just one method to respond to the twin anxieties of AIDS and unwanted pregnancy. In those couples in which the man refuses to wear a male condom, the availability of a female condom makes protection possible for the first time. Although the female condom has some advantages over the male condom--greater comfort for some women and men and nonreliance on male arousal--general population experience with the device is needed to achieve regular widespread use and hence effectiveness at population levels. The FDA still lags behind in responding to women's needs for information on AIDS and sexually transmitted disease.




This article has been cited by other articles:


Home page
Behav ModifHome page
L. Artz, M. Macaluso, J. Kelaghan, H. Austin, M. Fleenor, L. Robey, E. W. Hook III, and I. Brill
An Intervention to Promote the Female Condom to Sexually Transmitted Disease Clinic Patients
Behav Modif, March 1, 2005; 29(2): 318 - 369.
[Abstract] [PDF]


Home page
Am. J. Public HealthHome page
N. Van Devanter, V. Gonzales, C. Merzel, N. S. Parikh, D. Celantano, and J. Greenberg
Effect of an STD/HIV Behavioral Intervention on Women's Use of the Female Condom
Am J Public Health, January 1, 2002; 92(1): 109 - 115.
[Abstract] [Full Text] [PDF]


Home page
American Behavioral ScientistHome page
H. L. SURRATT, W. M. WECHSBERG, L. B. COTTLER, C. G. LEUKEFELD, H. KLEIN, and D. P. DESMOND
Acceptability of the Female Condom Among Women at Risk for HIV Infection
American Behavioral Scientist, May 1, 1998; 41(8): 1157 - 1170.
[Abstract]


Home page
Qual Health ResHome page
V. E. Gil
The New Female Condom: Attitudes and Opinions of Low-Income Puerto Rican Women at Risk for HIV/AIDS
Qual Health Res, May 1, 1995; 5(2): 178 - 203.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the American Public Health Association